Total assets · 2023–2025

Telix Pharmaceuticals total assets

$1.2B+23.8% · FY2025

Telix Pharmaceuticals (TLX) reported $1.2B in total assets for fiscal 2025, +23.8% year on year.

$277M2023$940M2024$1.2B2025
Telix Pharmaceuticals — Total assets, 2023–2025
Fiscal yearTotal assetsChangeFiling
FY20252025-12-31$1.2B+23.8%Open →
FY20242024-12-31$940M+239.2%Open →
FY20232023-12-31$277M—Open →

Total assets — Total assets is everything the company owns at the balance-sheet date. Banks and insurers dominate this measure because customer deposits and policy reserves sit on their balance sheets.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2023–2025 compound annual growth +104.9%

Figures are reported under IFRS, in US dollars.

Total assets at companies of similar size

Full ranking by total assets →

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Telix Pharmaceuticals total assets |url=https://companiesranked.com/en/company/telix-pharmaceuticals/total-assets |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Telix Pharmaceuticals total assets. CompaniesRanked. https://companiesranked.com/en/company/telix-pharmaceuticals/total-assets

BibTeX

@misc{companiesranked-en-company-telix-pharmaceuticals-total-assets-2026,
  author       = {{CompaniesRanked}},
  title        = {{Telix Pharmaceuticals total assets}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/telix-pharmaceuticals/total-assets}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 20-F · 0001628280-26-009943 · February 20, 2026

{{cite web |title=Telix Pharmaceuticals total assets — 20-F (0001628280-26-009943) |url=https://www.sec.gov/Archives/edgar/data/2007191/000162828026009943/tlx-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-20}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Telix Pharmaceuticals overview